Seaport Therapeutics, Inc.

US$21.50As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:SPTXHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM —
Mkt cap US$1.151B
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$27
26.16%
(62.81%)
Sell 0|0|11|7|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.19
0.21
0.23
0.22
(3.17%)
7.41%
18.68%
11.82%
Revenue$M
83.72
88.33
90.07
94.57
12.71%
15.88%
13.48%
16.65%
Peers (US$1.151B)
Cap (US$)
PE
1.225B
10.77x
1.221B
0.652x
1.214B
—
1.147B
—
Capital
TTM
5Y
10Y
Leveragex
0.812
0.078
0.068
EBIT/Intx
1.614
0.368
0.318
Own earn%
7.54
4.68
(1.57)
Sh yield%
26.82
64.29
61.34
Owners
Insiders/Inst%
0.19
57.41
Short interest%
4.86
SBC / revenue%
1.21
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
10–21
$1 testx
—
Incr. ROIC%
1